Free Trial

*** $5B Pfizer 7-part and $3B MUFG.........>

PIPELINE
PIPELINE: *** $5B Pfizer 7-part and $3B MUFG launch late, waiting on $1.5B
Unilever
Date $MM Issuer/Rating/Desc/Maturity/Yld/Leads; Priced *; Launch #:
09/04 $5B #Pfizer 7-part: $1B 3Y fix +32, $1B 5Y fix +47, $300M 5Y FRN +33, 
......$1B 10Y +72, $700M 20Y +105, $1B 30Y +115
09/04 $3B #MUFG, $1.15B 5Y fix +95, $850M 5Y FRN +81, $1B 10Y +115
09/04 $1.5B #Unilever capital $500M each: 3Y +42, 5Y +62, 10Y +72
09/04 $1.25B *Caterpillar $800M 3Y fix +45, $450M 3Y FRN L+28
09/04 $450M (upsized from $350M) #Duke Realty Ltd 10Y +123 
09/04 $3B EIB 3Y WNG MS+1a

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.